GGenetics Read More One-size-fits-(nearly)-all fix for V2R mutations4 October 2025 Genetic/congenital Genetic mutations are the primary cause of most rare diseases. Although each condition affects a small fraction…
GGenetics Read More Saol Therapeutics hit with CRL for rare genetic disease11 September 2025 The U.S. FDA issued a complete response letter (CRL) for the NDA to privately held Saol Therapeutics Inc.’s…
MMedication Read More Medicines Reimagined – Repurposing Drugs For New Indications30 August 2025 In a group of health-related headlines, one says “Hope for new drug approach. getty As government-supported research in…
GGenetics Read More Ionis gets approval for preventing attacks in rare and genetic HAE23 August 2025 In Ionis Pharmaceuticals Inc.’s second U.S. FDA approval in under a year, the agency approved Dawnzera (donidalorsen) as…
GGenetics Read More Bridging psychiatry and rare genetic diseases: a scoping review of therapeutic strategies and diagnostic delay paired with healthcare economic burden analysis | Orphanet Journal of Rare Diseases2 August 2025 Nguengang Wakap S, Lambert DM, Olry A, Rodwell C, Gueydan C, Lanneau V, Murphy D, Le Cam Y,…
GGenetics Read More Researchers classify how specific genetic mutations correspond to rare disorders30 July 2025 The NF-κB signaling pathway plays a pivotal role in how our bodies fight infection, heal, and regulate inflammation.…
EEU Read More Europe moves to reject embattled Duchenne gene therapy25 July 2025 Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
GGenetics Read More UConn, Connecticut Children’s trial gene-editing for rare disease17 July 2025 Julieta Bonvin Sallago is constantly plagued by the worry that she will not wake up in the middle…
GGenetics Read More Study Links Gout and GCKR Gene18 June 2025 Image Credit: Adobe Stock Results from a recent systematic review and meta-analysis of the relation between single-nucleotide polymorphism…
MMedication Read More FDA denies Barth syndrome drug approval, suggests accelerated pathway29 May 2025 For the past decade, Stealth BioTherapeutics has ridden a rollercoaster trying to convince the Food and Drug Administration…